NY Times: What to Know About the Covid Antibody Drugs That Could Help Many

Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.

By Katie Thomas and Rebecca Robbins
Dec. 23, 2020

Two new antibody treatments have shown promise in keeping high-risk Covid-19 patients out of the hospital.

But despite getting a publicity boost from President Trump, who received the Regeneron treatment in October and praised it as a “cure,” the drugs have not been widely used since being authorized for emergency use last month by the Food and Drug Administration.

Now, federal and state health officials are urging patients and doctors to seek out the treatments.

Here’s what you need to know.

Read the Article on the New York Times

NY Times: What to Know About the Covid Antibody Drugs That Could Help Many
Scroll to top